missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ DOCK2 Monoclonal Antibody (OTI4E12)

Description
DOCK2 Monoclonal Antibody for IHC (P)
Dedicator of cytokinesis 2 (DOCK2) is a gene located on chromosome 5q15, encoding a member of the DOCK family of guanine nucleotide exchange factors (GEFs). DOCK2 plays a crucial role in the immune system by regulating the actin cytoskeleton, which is essential for cell movement and immune cell activation. It is predominantly expressed in hematopoietic cells, including lymphocytes and other leukocytes, where it facilitates chemotaxis and polarization by activating the small GTPase Rac. This activation is critical for processes such as lymphocyte homing, migration towards chemokines, and phagocytosis. Genetic mutations or dysregulation of DOCK2 can lead to immunodeficiency, characterized by impaired immune responses and increased susceptibility to infections. Research into DOCK2 focuses on its therapeutic potential in modulating immune responses and its role in disorders characterized by immune dysregulation, such as autoimmune diseases and chronic inflammation.
Specifications
Specifications
| Antigen | DOCK2 |
| Applications | Immunohistochemistry (Paraffin) |
| Classification | Monoclonal |
| Clone | OTI4E12 |
| Concentration | 1 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 1% BSA, 50% glycerol and 0.02% sodium azide; pH 7.3 |
| Gene | DOCK2 |
| Gene Accession No. | Q92608 |
| Gene Alias | AI662014; AW122239; CED-5; dedicator of cytokinesis 2; dedicator of cyto-kinesis 2; dedicator of cytokinesis protein 2; DOCK2; FLJ46592; Hch; IMD40; KIAA0209; LOW QUALITY PROTEIN: dedicator of cytokinesis protein 2; MBC; Protein Hch |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?